- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05053191
Advancing Nursing Practices in Hospital Oncology Care
September 18, 2025 updated by: Memorial Sloan Kettering Cancer Center
Advancing Family-Centered Care Nursing Practices in Inpatient Oncology Care
The purpose of this study is to find out if a new training program for nurses called PACT (Partnership, Assessment, Care, and Transition) will be effective and relevant in helping nurses gain the skills needed to provide high-quality family-centered care.
Family-centered care skills include engaging family caregivers as partners in patient care, and strengthening their capacity for caregiving by assessing family support needs and facilitating access to resources when needed.
The study will also look at whether the quality of nurses' family-centered care skills is associated with improved outcomes for family caregivers.
Both nurses and family caregivers will be enrolled in this study.
Participants will be nurses/caregivers who care for advanced GI cancer patients admitted to Memorial Sloan Kettering.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Nurses:
- MSKCC day-shift nurses and/or night-shift nurses (Clinical Nurse I to IV) assigned to the GI inpatient unit (M16) at the time of study, all of whom provide initial and ongoing assessment of patients' physical, psychosocial, cultural and informational needs
- Nurse is comfortable speaking and reading English as per self report
Family caregivers (FC) - Phase 1b:
Adult (≥18 yrs) family caregiver (family caregiver is defined here as any informal caregiver who is a relative, friend or legal representative) who self-identifies and/or is identified by the nursing staff as involved in the care of an MSK cancer patient who either:
- is currently admitted to the M16 unity for at least 12 hours OR
- has been discharged from the M16 unit within the last 2 weeks
- English-speaking as per self-report
- Only one FC per patient case will be invited to participate.
M16 Patients (chart review only):
- Adult (≥18 yrs) cancer patient who is currently admitted in the M16 unit at Memorial Hospital for at least 12 hours o English speaking as per self-report
Exclusion Criteria:
Nurses:
- Nurse plans to leave MSK or the GI unit within 3 months as per self-report
- [Phases 2-4] Nurse refuses observation of consultations as per self-report
Family caregivers (FC) - Phase 1b:
- FC's patient is deceased at time of consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nurses
MSKCC day-shift nurses (Clinical Nurse I to IV) assigned to the GI inpatient unit (MH16) at the time of study, all of whom provide initial and ongoing assessment of patients' physical, psychosocial, cultural and informational needs
|
Partnership, Assessment, Care and Transition to psychosocial resources.
Nurses who participate in PACT will receive 8 hours of training in a single, full-day workshop.
We will train nurses in clusters of 10-12 nurses at one time, which will allow for cross-coverage with minimal disruption to workflow, and provide a more intimate, small-group learning environment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of nurses' use of family centered care practices
Time Frame: 30 days
|
Frequency of nurses' use of family centered care practices as observed during inpatient consultations with family caregivers
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Talia Zaider, PhD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 3, 2021
Primary Completion (Estimated)
September 3, 2026
Study Completion (Estimated)
September 3, 2026
Study Registration Dates
First Submitted
September 14, 2021
First Submitted That Met QC Criteria
September 21, 2021
First Posted (Actual)
September 22, 2021
Study Record Updates
Last Update Posted (Estimated)
September 19, 2025
Last Update Submitted That Met QC Criteria
September 18, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-448
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials.
The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov
when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required.
Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication.
Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals.
Requests may be made to: crdatashare@mskcc.org.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Cancer
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Gastrointestinal Cancer | Gastrointestinal Cancer MetastaticUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Dartmouth-Hitchcock Medical Center; West Virginia... and other collaboratorsCompletedGynecologic Cancer | Thoracic Cancer | Gastrointestinal Cancer | Other CancerUnited States
-
Royal Marsden NHS Foundation TrustMerck KGaA, Darmstadt, Germany; 4SC AGUnknownCancer | GI CancerUnited Kingdom
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtRecruitingGastrointestinal Cancer MetastaticNetherlands
-
University Medical Center GroningenCompleted
-
Bristol-Myers SquibbCompletedUpper Gastrointestinal CancerCanada
-
Sumitomo Pharma America, Inc.CompletedAdvanced Gastrointestinal CancerUnited States, Canada
-
Goethe UniversityAgaplesion Markus Krankenhaus gGmbHCompletedAdvanced Gastrointestinal CancerGermany
-
Yonsei UniversitySmall and Medium Business AdministrationCompletedUpper Gastrointestinal CancerKorea, Republic of
-
Boehringer IngelheimCompletedGastrointestinal Cancer, MetastaticBelgium, United States, France, Japan, China
Clinical Trials on Partnership, Assessment, Care and Transition training intervention
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMalignant Neoplasm | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
McMaster UniversityCompletedInflammatory Bowel Diseases | Juvenile Idiopathic ArthritisCanada
-
University of FloridaPatient-Centered Outcomes Research InstituteCompletedED Patients With Chronic Medical IllnessesUnited States
-
MetroHealth Medical CenterCleveland Metropolitan School District; Environmental Health Watch; Legal Aid...CompletedAsthma | Pediatric ALL | Medical Informatics | Social Determinants of Health | School Health Services | Registries | Home Visits | Housing Problems | Healthcare Disparity | Health Status DisparityUnited States
-
East Carolina UniversityNational Cancer Institute (NCI)CompletedDepression | Prostate Cancer | Cancer Survivor | Psychosocial Effects of Cancer and Its Treatment | Gastrointestinal Complications | Male Erectile Disorder | Urinary ComplicationsUnited States
-
University of FloridaEmergency Medicine FoundationCompletedED Patients With Chronic Medical IllnessesUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH)WithdrawnAutism Spectrum Disorder
-
Emory UniversityNational Institute of Nursing Research (NINR)Completed
-
Brown UniversityNational Institute of Mental Health (NIMH); University of Cape TownCompletedHIV | Pregnancy RelatedSouth Africa
-
University of AlbertaActive, not recruiting